HAAS JASON sold 56.5% of their position (6.46K shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market sale worth $1.65M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+3K
Price / share
$51.56
Trade value
$154.68K
% of position
Common Stock
Shares
+1K
Price / share
$51.56
Trade value
$51.56K
% of position
Common Stock
Shares
−3K
Price / share
$255.01
Trade value
$765.03K
% of position
Common Stock
Shares
−3.46K
Price / share
$256.08
Trade value
$886.29K
% of position
Net shares
−2.46K
Net value
-$1.45M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/12/2026 | M · Option Exercise | +3K | $51.56 | $154.68K | 40.3% | 7.44K | 10.44K |
| Common Stock Direct | 6/12/2026 | M · Option Exercise | +1K | $51.56 | $51.56K | 9.6% | 10.44K | 11.44K |
| Common Stock Direct | 6/12/2026 | S · Sale | −3K | $255.01 | $765.03K | 26.2% | 11.44K | 8.44K |
| Common Stock Direct | 6/12/2026 | S · Sale | −3.46K | $256.08 | $886.29K | 41.0% | 8.44K | 4.98K |
| Total | −2.46K | -$1.45M | ||||||
Non-Qualified Stock Option (right to buy)
Common Stock
3K shares
Shares
−3K
Strike price
51.56
Held after
7.14K
Exercisable
—
Non-Qualified Stock Option (right to buy)
Common Stock
1K shares
Shares
−1K
Strike price
51.56
Held after
6.14K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock3K shares | 6/12/2026 | M · Option Exercise | −3K | 51.56 | — | 7.14K |
| Non-Qualified Stock Option (right to buy) Direct | Common Stock1K shares | 6/12/2026 | M · Option Exercise | −1K | 51.56 | — | 6.14K |